Amerant Bancorp (AMTB) Reports Q4 Earnings Decline but Beats Estimates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 23 2026
0mins
Source: NASDAQ.COM
- Earnings Performance: Amerant Bancorp reported Q4 earnings of $2.70 million, or $0.07 per share, a significant decline from last year's $16.88 million and $0.40 per share, yet it surpassed analysts' expectations of $0.35, demonstrating resilience amid challenges.
- Adjusted Earnings: Excluding special items, the company reported adjusted earnings of $21.67 million, or $0.53 per share, indicating that its core operations remain profitable despite the overall earnings decline.
- Revenue Growth: The company's revenue for the fourth quarter rose 0.8% to $112.17 million from $111.32 million last year, reflecting stable revenue streams despite market challenges.
- Market Expectations: Although earnings declined, Amerant's performance exceeded market expectations, potentially boosting investor confidence and indicating the company's potential for improved profitability in future quarters.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AMTB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AMTB
Wall Street analysts forecast AMTB stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 22.910
Low
23.00
Averages
23.67
High
25.00
Current: 22.910
Low
23.00
Averages
23.67
High
25.00
About AMTB
Amerant Bancorp Inc. is a bank holding company. The Company operates through its subsidiary, Amerant Bank, N.A. (the Bank). It provides individuals and businesses with a comprehensive array of deposit, credit, investment, wealth management, retail banking, mortgage services and fiduciary services. It offers a variety of trust and estate planning products and services catering to high-net-worth customers. Its trust and estate planning products include simple and complex trusts, private foundations and personal investment companies. It offers a full suite of online banking services, including online account opening for domestic and international customers, access to account balances, statements and other documents, Zelle for consumers and businesses, online transfers, online bill payment and electronic delivery of customer statements, as well as automated teller machines, and banking by mobile devices, telephone and mail.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Zacks Adds Three Stocks to Strong Sell List
- Amerant Bancorp Downgrade: Amerant Bancorp (AMTB) has seen its Zacks consensus estimate for current year earnings revised down by nearly 13.7% over the past 60 days, indicating a significant loss of market confidence that could lead to stock sell-offs and negatively impact its price performance.
- ADMA Biologics Earnings Drop: ADMA Biologics (ADMA) has experienced a downward revision of approximately 12.5% in its current year earnings estimate by Zacks over the last 60 days, reflecting increased competitive pressures in the biopharmaceutical market that may affect its future financing capabilities and market share.
- Adecco Earnings Decline: Adecco (AHEXY) has had its current year earnings consensus estimate revised down by 9% in the past 60 days, which could weaken its competitive position in the recruitment market and impact its ability to acquire and retain clients.
- Zacks Strong Sell List: These three stocks have been added to the Zacks Rank #5 (Strong Sell) list, indicating analysts' pessimistic outlook on their future performance, prompting investors to carefully assess the risks of holding these stocks.
See More
Amerant Bancorp Appoints New CEO
- Executive Appointment: Amerant Bancorp announced that Carlos Iafigliola will officially take over as President and CEO on May 18, 2026, after serving as interim CEO since November 2025, reflecting the company's confidence in his leadership capabilities.
- Subsidiary Leadership: Iafigliola is also appointed as President and CEO of Amerant Bank, indicating the company's intent to leverage his experience to enhance the competitiveness and market position of its primary banking operations.
- Shareholder Confidence: The board expresses strong confidence in Iafigliola's ability to strengthen the business and support long-term shareholder value, even as the stock closed slightly lower at approximately $22.25.
- Future Outlook: Amerant projects deposits of $8 billion for Q2 2026 and targets a ~60% efficiency ratio, suggesting that the company is actively seeking growth opportunities driven by inflows from Venezuela.
See More
Amerant (AMTB) Q1 2026 Earnings Call Transcript
See More
Amerant Bancorp Q1 2026 Earnings Call Insights
- Loan Portfolio Optimization: Amerant Bancorp successfully transferred a group of loans to held for sale in Q1 2026, focusing on borrowers with proven stable operating histories, which reduces risk and enhances credit quality, positively impacting future loan growth expectations.
- Significant Cost Management: The company achieved approximately $30 million in cost savings in Q1, with noninterest expenses decreasing by 37.3% quarter-over-quarter, indicating effective cost control measures that enhance financial stability and profitability.
- Strong Deposit Growth: Total deposit growth reached $188 million in Q1, with $95 million coming from Venezuela, highlighting the market's stability and attractiveness, which is expected to support future funding costs and rate increases.
- Optimistic Outlook: Management projects loan balances to reach approximately $7 billion by Q2 2026 and deposits to hit $8 billion, with an annualized loan growth rate of about 7%, indicating that the company's sustainable growth strategy under risk management is being effectively implemented.
See More
Amerant Bancorp Q1 Earnings Beat Expectations
- Earnings Beat: Amerant Bancorp reported a Q1 GAAP EPS of $0.44, exceeding expectations by $0.01, indicating a stable profitability and potential for growth amidst market fluctuations.
- Revenue Miss: The company's revenue of $97.66 million fell short of the $100 million forecast by $3.09 million, reflecting increased market competition and fluctuations in loan demand that could impact future performance.
- Stabilizing CRE Loans: Amerant highlighted that commercial real estate loans are stabilizing, suggesting potential growth opportunities ahead, which is crucial for enhancing overall financial performance and shareholder confidence.
- Strong Small-Cap Performance: Amerant Bancorp's stock has surged above the 200-day moving average, indicating strong performance among small-cap financial stocks and reflecting market optimism regarding its future prospects.
See More
Amerant Bancorp Reports $17.9 Million Net Income for Q1 2026
- Net Income Surge: Amerant Bancorp reported a net income of $17.9 million for Q1 2026, translating to $0.44 earnings per diluted share, a significant increase from $2.7 million and $0.07 per share in Q4 2025, demonstrating the company's effective execution of its strategic plan and enhanced profitability.
- Asset and Loan Growth: As of Q1 2026, total assets reached $9.9 billion, up 1.3% from the previous quarter, while total loans amounted to $6.8 billion, reflecting a 0.8% increase, indicating effective measures in optimizing the loan portfolio and managing credit risk.
- Significant Reduction in Non-Interest Expenses: Non-interest expenses totaled $66.9 million, down 37.3% from Q4 2025, primarily due to cost savings from vendor contract renegotiations, showcasing the company's ongoing improvements in operational efficiency.
- Shareholder Returns and Dividends: The company's Board of Directors declared a cash dividend of $0.09 per share, payable on May 29, 2026, reflecting a strong commitment to shareholder returns and stable financial performance.
See More
Zacks Adds Three Stocks to Strong Sell List
- Amerant Bancorp Downgrade: Amerant Bancorp (AMTB) has seen its Zacks consensus estimate for current year earnings revised down by nearly 13.7% over the past 60 days, indicating a significant loss of market confidence that could lead to stock sell-offs and negatively impact its price performance.
- ADMA Biologics Earnings Drop: ADMA Biologics (ADMA) has experienced a downward revision of approximately 12.5% in its current year earnings estimate by Zacks over the last 60 days, reflecting increased competitive pressures in the biopharmaceutical market that may affect its future financing capabilities and market share.
- Adecco Earnings Decline: Adecco (AHEXY) has had its current year earnings consensus estimate revised down by 9% in the past 60 days, which could weaken its competitive position in the recruitment market and impact its ability to acquire and retain clients.
- Zacks Strong Sell List: These three stocks have been added to the Zacks Rank #5 (Strong Sell) list, indicating analysts' pessimistic outlook on their future performance, prompting investors to carefully assess the risks of holding these stocks.
See More
Amerant Bancorp Appoints New CEO
- Executive Appointment: Amerant Bancorp announced that Carlos Iafigliola will officially take over as President and CEO on May 18, 2026, after serving as interim CEO since November 2025, reflecting the company's confidence in his leadership capabilities.
- Subsidiary Leadership: Iafigliola is also appointed as President and CEO of Amerant Bank, indicating the company's intent to leverage his experience to enhance the competitiveness and market position of its primary banking operations.
- Shareholder Confidence: The board expresses strong confidence in Iafigliola's ability to strengthen the business and support long-term shareholder value, even as the stock closed slightly lower at approximately $22.25.
- Future Outlook: Amerant projects deposits of $8 billion for Q2 2026 and targets a ~60% efficiency ratio, suggesting that the company is actively seeking growth opportunities driven by inflows from Venezuela.
See More
Amerant (AMTB) Q1 2026 Earnings Call Transcript
See More
Amerant Bancorp Q1 2026 Earnings Call Insights
- Loan Portfolio Optimization: Amerant Bancorp successfully transferred a group of loans to held for sale in Q1 2026, focusing on borrowers with proven stable operating histories, which reduces risk and enhances credit quality, positively impacting future loan growth expectations.
- Significant Cost Management: The company achieved approximately $30 million in cost savings in Q1, with noninterest expenses decreasing by 37.3% quarter-over-quarter, indicating effective cost control measures that enhance financial stability and profitability.
- Strong Deposit Growth: Total deposit growth reached $188 million in Q1, with $95 million coming from Venezuela, highlighting the market's stability and attractiveness, which is expected to support future funding costs and rate increases.
- Optimistic Outlook: Management projects loan balances to reach approximately $7 billion by Q2 2026 and deposits to hit $8 billion, with an annualized loan growth rate of about 7%, indicating that the company's sustainable growth strategy under risk management is being effectively implemented.
See More
Amerant Bancorp Q1 Earnings Beat Expectations
- Earnings Beat: Amerant Bancorp reported a Q1 GAAP EPS of $0.44, exceeding expectations by $0.01, indicating a stable profitability and potential for growth amidst market fluctuations.
- Revenue Miss: The company's revenue of $97.66 million fell short of the $100 million forecast by $3.09 million, reflecting increased market competition and fluctuations in loan demand that could impact future performance.
- Stabilizing CRE Loans: Amerant highlighted that commercial real estate loans are stabilizing, suggesting potential growth opportunities ahead, which is crucial for enhancing overall financial performance and shareholder confidence.
- Strong Small-Cap Performance: Amerant Bancorp's stock has surged above the 200-day moving average, indicating strong performance among small-cap financial stocks and reflecting market optimism regarding its future prospects.
See More
Amerant Bancorp Reports $17.9 Million Net Income for Q1 2026
- Net Income Surge: Amerant Bancorp reported a net income of $17.9 million for Q1 2026, translating to $0.44 earnings per diluted share, a significant increase from $2.7 million and $0.07 per share in Q4 2025, demonstrating the company's effective execution of its strategic plan and enhanced profitability.
- Asset and Loan Growth: As of Q1 2026, total assets reached $9.9 billion, up 1.3% from the previous quarter, while total loans amounted to $6.8 billion, reflecting a 0.8% increase, indicating effective measures in optimizing the loan portfolio and managing credit risk.
- Significant Reduction in Non-Interest Expenses: Non-interest expenses totaled $66.9 million, down 37.3% from Q4 2025, primarily due to cost savings from vendor contract renegotiations, showcasing the company's ongoing improvements in operational efficiency.
- Shareholder Returns and Dividends: The company's Board of Directors declared a cash dividend of $0.09 per share, payable on May 29, 2026, reflecting a strong commitment to shareholder returns and stable financial performance.
See More
